[CIS PIDD] [cis-pidd] IGSC for autoimmune disorders

CIS-PIDD cis-pidd at lists.clinimmsoc.org
Wed Jun 15 18:59:38 EDT 2016


Joe,

There is a small published literature on efficacy of transitioning patients with immune mediated neurologic diseases like CIDP from high-dose IVIG to SCIG - it works and the advantage is that they don't see the tail-off effect with return of symptoms prior to next dose like they see using IV administration.

T

Troy R. Torgerson, MD PhD

Associate Professor of Pediatrics
Divisions of Immunology/Rheumatology
Director, Immunology Diagnostic Lab (IDL)
Co-Director, Non-Malignant Transplant Program
University of Washington and Seattle Children's Hospital

Address:
Seattle Children's Research Institute
1900 9th Ave., C9S-7
Seattle, WA  98101-1304

Phone:  (206) 987-7317
Fax:  (206) 987-7310
Email:  troy.torgerson at seattlechildrens.org

IDL lab:  www.seattlechildrens.org/idl



From: CIS-PIDD <cis-pidd at lists.clinimmsoc.org<mailto:cis-pidd at lists.clinimmsoc.org>>
Reply-To: CIS-PIDD <cis-pidd at lyris.dundee.net<mailto:cis-pidd at lyris.dundee.net>>
Date: Wednesday, June 15, 2016 at 3:53 PM
To: CIS-PIDD <cis-pidd at lyris.dundee.net<mailto:cis-pidd at lyris.dundee.net>>
Subject: RE:[cis-pidd] IGSC for autoimmune disorders

Yes, we have. We split it into twice weekly doses (was actually about 1.5g/kg) Patient tolerated fine and it worked well. He  had autoimmune c ytopenias which were refractory to multiple immune suppressives and had IV access issues.


Mary Hintermeyer
Advanced Practice Nurse Practitioner
Primary Immune Deficiency Program
Children's Hospital of Wisconsin
Jeffrey Modell  Diagnostic and Research Center for Primary Immunodeficiencies
PH: 414-266-6293  FAX: 414-266-1649



From: CIS-PIDD [mailto:cis-pidd at lists.clinimmsoc.org]
Sent: Wednesday, June 15, 2016 5:50 PM
To: CIS-PIDD
Subject: [cis-pidd] IGSC for autoimmune disorders

Colleagues:

Has anyone used the subcutaneous route to administer 'high dose' immunoglobulin (2g/kg) to patients with autoimmune disease?

Joe Church
Children's Hospital Los Angeles

---------------------------------------------------------------------
CONFIDENTIALITY NOTICE: This e-mail message, including any attachments,
is for the sole use of the intended recipient(s) and may contain confidential
or legally privileged information. Any unauthorized review, use, disclosure
or distribution is prohibited. If you are not the intended recipient, please
contact the sender by reply e-mail and destroy all copies of this original message.

---------------------------------------------------------------------

---

You are currently subscribed to cis-pidd as: mhintermeyer at chw.org<mailto:mhintermeyer at chw.org>.

To unsubscribe click here: http://cts.dundee.net/u?id=100610740.31c1bb93a6d33efcd7184acdbc9afed1&n=T&l=cis-pidd&o=3698364<https://urldefense.proofpoint.com/v2/url?u=http-3A__cts.dundee.net_u-3Fid-3D100610740.31c1bb93a6d33efcd7184acdbc9afed1-26n-3DT-26l-3Dcis-2Dpidd-26o-3D3698364&d=DQMFAg&c=aBkXpkKi7gN5fe5MqrMaN-VmRugaRb1IDRfSv2xVRy0&r=B65vEHIdrYlzBW9zPeVVPIWTsn3KBbR1LMxIXn5BZBWY1KFZLF-1zlX53TtwBSSF&m=JHq5TB_GBhK1yXeGUsaKpKWhqhYIqK8MMqZ4CZoIzxo&s=dF_sDBUIvt8_mE8XAxubJSBN92aCjaWO44OrAqYDoAU&e=>

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-3698364-100610740.31c1bb93a6d33efcd7184acdbc9afed1 at lyris.dundee.net<mailto:leave-3698364-100610740.31c1bb93a6d33efcd7184acdbc9afed1 at lyris.dundee.net>

This message originates from Children's Hospital of Wisconsin, and may contain information that is privileged and confidential. It is intended only for the use of the designated recipient. Any review, dissemination, distribution, or copying of this message by anyone other than the intended recipient is prohibited. All personal messages express views solely of the sender, are not to be attributed to Children's Hospital of Wisconsin, and may not be copied or distributed without this disclaimer. If you have received this message in error, please notify the sender and destroy the original message. Thank you.

---

You are currently subscribed to cis-pidd as: troy.torgerson at seattlechildrens.org<mailto:troy.torgerson at seattlechildrens.org>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396927.ea8d10e56fb822c94006714cc459df78&n=T&l=cis-pidd&o=3698367<https://urldefense.proofpoint.com/v2/url?u=http-3A__cts.dundee.net_u-3Fid-3D96396927.ea8d10e56fb822c94006714cc459df78-26n-3DT-26l-3Dcis-2Dpidd-26o-3D3698367&d=DQMFAg&c=aBkXpkKi7gN5fe5MqrMaN-VmRugaRb1IDRfSv2xVRy0&r=B65vEHIdrYlzBW9zPeVVPIWTsn3KBbR1LMxIXn5BZBWY1KFZLF-1zlX53TtwBSSF&m=JHq5TB_GBhK1yXeGUsaKpKWhqhYIqK8MMqZ4CZoIzxo&s=3CPhPWFhXw0eF32JUBmTvRLWMm9ENGdFnJxbZKQVntU&e=>

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-3698367-96396927.ea8d10e56fb822c94006714cc459df78 at lyris.dundee.net<mailto:leave-3698367-96396927.ea8d10e56fb822c94006714cc459df78 at lyris.dundee.net>

CONFIDENTIALITY NOTICE: This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information protected by law. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message.

---
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://cts.dundee.net/u?id=96396833.5a9591ccd1e327fe6bc4d1543298c482&n=T&l=cis-pidd&o=3698378
or send a blank email to leave-3698378-96396833.5a9591ccd1e327fe6bc4d1543298c482 at lyris.dundee.net
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20160615/3661c983/attachment-0001.html>


More information about the PAGID mailing list